Intragastric Balloons Market: Industry Analysis and Research Report 2024: Global Market Insights Inc. The medical research report “Intragastric Balloon Market Size By Product (Single, Dual, Triple), By Filling Material (Saline, Gas), By End-use (Hospitals, Ambulatory Surgical Centers, Clinics), Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, France, Spain, Italy, Russia, Poland, Japan, India, China, Australia, Malaysia, Indonesia, Thailand, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE, Egypt), Application Growth Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024”, Intragastric Balloons Market size is expected to exceed USD 270 million by 2024; as per a new research report by Global Market Insights. Extensive use of intragastric balloons owing to cost advantage and presence of large number of industry players offering low priced products should stimulate business demand. The low cost of intragastric balloons compared with other invasive surgical procedures should drive industry growth.
Technological innovation coupled with reduced costs associated with treatment, short hospital stay and reduced recovery time will boost intragastric balloons market growth. Some of the factors such as erosion, damage to the esophagus, persistent nausea and vomiting and bacterial growth within the balloon may hamper demand in the coming years. The 2015 single intragastric balloons market share, was over 50% of global revenue, with more than 8% CAGR predicted, due to growing awareness coupled with increasing acceptance of non-invasive procedures. Saline filled balloons are set to witness over 9% CAGR, the ability to reduce weight and easy detection of deflation due to methylene blue should stimulate business growth. The 2015 global industry demand in hospitals was valued at over USD 45 million. Availability of highly skilled professionals, increased preference towards hospitals and high funding opportunities will accelerate industry growth. Some of the prominent industry participants are Apollo Endosurgery, Allurion technologies, ReShape Medical, Obalon therapeutics, Helioscopie Medical Implants, Spatz FGIA. U.S. intragastric balloons market share will be driven by the favorable government initiatives and improved awareness levels. Obesity continues to be a growing epidemic increasing the risk of premature death from stroke, gall bladder, type-II diabetes and some cancers. 1|Page